One Word_Biochemistry Flashcards
(148 cards)
1
Q
α-amanitin
A
(found in death cap mushrooms) inhibits RNA polymerase II. Causes liver failure if ingested
2
Q
Zinc
A
Function: Essential for the activity of 100+ enzymes. Important in the formation of zinc fingers (transcription factor motif) Deficiency: Delayed wound healing, hypogonadism, ↓ adult hair (axillary, facial, pubic), dysgeusia, anosmia. May predispose to alcoholic cirrhosis.
3
Q
Type IV collagen (3)
A
Basement membrane or basal lamina (maybe lens?)
4
Q
Type III collagen - Reticulin (5)
A
skin, blood vessels, uterus, fetal tissue, granulation tissue
5
Q
Type II collagen (3)
A
Cartilage (including hyaline), vitreous body, nucleus pulposus
6
Q
Type I collagen (7)
A
Bone, Skin, Tendon, dentin, fascia, cornea, late wound repair
7
Q
Trinucleotide repeat expansion diseases
A
Huntington’s disease = (CAG)n Myotonic dystrophy = (CTG)n Fragile X syndrome = (CGG)n Friedreich’s ataxia = (GAA)n
8
Q
Treatment: Pyruvate dehydrogenase deficiency
A
Lysine and Leucine - the only purely ketogenic amino acids
9
Q
Treatment: Orotic aciduria
A
Oral uridine administration
10
Q
Transversion
A
Substituting purine for pyrimidine or vice versa
11
Q
Transition
A
Substituting purine for purine or pyrimidine for pyrimidine
12
Q
Toxicity: Arsenic
A
inhibits lipoic acid, causes vomiting, rice water stools, garlic breath
13
Q
Rate-determining enzymes of metabolic processes - Urea cycle
A
Carbamoyl phosphate synthetase I
14
Q
Rate-determining enzymes of metabolic processes - TCA cycle
A
Isocitrate dehydrogenase
15
Q
Rate-determining enzymes of metabolic processes - Ketogenesis
A
HMG-CoA synthase
16
Q
Rate-determining enzymes of metabolic processes - HMP shunt
A
Glucose-6-phosphate dehydrogenase (G6PD)
17
Q
Rate-determining enzymes of metabolic processes - Glycolysis
A
Phosphofructokinase-1 (PFK-1)
18
Q
Rate-determining enzymes of metabolic processes - Glycogenolysis
A
Glycogen phosphorylase
19
Q
Rate-determining enzymes of metabolic processes - Glycogen synthesis
A
Glycogen synthase
20
Q
Rate-determining enzymes of metabolic processes - Gluconeogenesis
A
Fructose-1,6-biphosphatase
21
Q
Rate-determining enzymes of metabolic processes - Fatty acid synthesis
A
Acetyl-CoA carboxylase (ACC)
22
Q
Rate-determining enzymes of metabolic processes - Fatty acid oxidation
A
Carnithine acyltransferase I
23
Q
Rate-determining enzymes of metabolic processes - De novo pyrimidine synthesis
A
Carbamoyl phosphate synthetase II
24
Q
Rate-determining enzymes of metabolic processes - De novo purine synthesis
A
Glutamine-PRPP amidotransferase
25
Rate-determining enzymes of metabolic processes - Cholesterol synthesis
HMG-CoA reductase
26
Pyruvate dehydrogenase complex
The complex contains 3 enzymes that require 5 cofactors: 1. Pyrophosphate (B1); 2. FAD (B2); 3. NAD (B3); 4. CoA (B5); 5. Lipoic acid Activated by exercise: ↑NAD+/NADH ratio, ↑ADP, ↑Ca2+
27
Pyrimidines are made from?
Orotate precursor, with PRPP added later
28
Purines are made from?
IMP precursor
29
Prader-Willi syndrome
Deletion of normally active Paternal allele Mental retardation, hyperphagia, obesity, hypogonadism, hypotonia
30
Ornithine transcarbamoylase deficiency
(↓urea cycle), leads to an accumulation of carbamoyl phosphate, which is then converted to orotic acid
31
Octamer subunit amino acids
Lysine and Arginine
32
Nucleotide that has a methyl
Thymine
33
Nucleotide that has a ketone
Guanine
34
mRNA start codons code for?
Eukaryotes: Methionine Prokaryotes: Formyl-methionine (f-Met)
35
Molecular motor proteins: Kinesin
anterograde to microtubule
36
Molecular motor proteins: Dynein
retrograde to microtubule
37
Modes of inheritance - Mitochondrial myopathies
Mitochondrial inheritance
38
Modes of inheritance - Leber's hereditary optic neuropathy
Mitochondrial inheritance, degeneration of retinal ganglion cells and axons. Leads to acute loss of central vision.
39
Modes of inheritance - Hypophosphatemic rickets
formerly known as vitamin D resistant rickets. Inherited X-linked dominant disorder resulting in ↑ phosphate wasting at proximal tubule. Results in rickets-like presentation.
40
MOA: Trimethoprim
inhibits bacterial dihydrofolate reductase (↓dTMP)
41
MOA: Tetracyclines
bind 30S subunit, preventing attachment of aminoacyl-tRNA
42
MOA: Quabain
inhibits by binding to K+ site
43
MOA: Orotic aciduria
Inability to convert orotic acid to UMP (de novo pyrimidine synthesis pathway) due to defect in either orotic acid phosphoribosyltransferase or ototidine 5'-phosphate decarboxylase. Autosomal recessive.
44
MOA: Methotrexate (MTX)
inhibits dihydrofolate reductase (↓dTMP)
45
MOA: Macrolides
bind 50S, blocking translocation
46
MOA: Hydroxyurea
inhibits ribonucleotide reductase
47
MOA: Clindamycin
binds 50S, blocking translocation
48
MOA: Chloramphenicol
inhibits 50S peptidyltransferase
49
MOA: Cardiac glycosides (digoxin and digitoxin)
directly inhibit the Na+-K+ ATPase, which leads to indirect inhibition of Na+/Ca2+ exchange. ↑ [Ca2+]i → ↑ cardiac contractility.
50
MOA: Aminoglycosides
inhibit formation of the initiation complex and cause misreading of mRNA
51
MOA: 6-mercaptopurine (6-MP)
blocks de novo purine synthesis
52
MOA: 5-fluorouracil (5-FU)
inhibits thymidylate synthase (↓dTMP)
53
Metabolism sites - Mitochondria (4)
Fatty acid oxidation (β-oxidation), acetyl-CoA production, TCA cycle, oxidative phosphorylation
54
Metabolism sites - Cytoplasm (5)
Glycolysis, fatty acid synthesis, HMP shunt, protein synthesis (RER), steroid synthesis (SER)
55
Metabolism sites - Both (3)
Heme synthesis, Urea cycle, Gluconeogenesis (HUGs takes two)
56
Marfan's syndrome
caused by a defect in fibrillin
57
Marasmus
energy malnutrition resulting in tissue and muscle wasting, loss of subcutaneous fat, and variable edema.
58
Major apolipoproteins - E
Mediates extra (remnant) uptake
59
Major apolipoproteins - C-II
Cofactor for lipoprotein lipase
60
Major apolipoproteins - B-48
Mediates chylomicron secretion
61
Major apolipoproteins - B-100
Binds to LDL receptor, mediates VLDL secretion
62
Major apolipoproteins - A-I
Activates LCAT
63
Lysosomal storage diseases - Tay-Sachs disease
Findings: Progressive neurodegeneration, developmental delay, cherry-red spot on macula, lysosomes with onion skin, no hepatosplenomegaly (vs. Niemann-Pick) Deficient enzyme: Hexosaminidase A Accumulated substrate: GM2 ganglioside Inheritance: AR
64
Lysosomal storage diseases - Niemann-Pick disease
Findings: Progressive neurodegeneration, hepatosplenomegaly, cherry-red spot on macula, foam cells Deficient enzyme: Sphingomyelinase Accumulated substrate: Sphingomyelin Inheritance: AR
65
Lysosomal storage diseases - Metachromatic leukodystrophy
Findings: Central and peripheral demyelination with ataxia, dementia Deficient enzyme: Arylsulfatase A Accumulated substrate: Cerebroside sulfate Inheritance: AR
66
Lysosomal storage diseases - Krabbe's disease
Findings: Peripheral neuropathy, developmental delay, optic atrophy, globoid cells Deficient enzyme: Galactocerebrosidase Accumulated substrate: Galactocerebroside Inheritance: AR
67
Lysosomal storage diseases - Hurler's syndrome
Findings: Developmental delay, gargoylism, airway obstruction, corneal clouding, hepatosplenomegaly Deficient enzyme: α-L-iduronidase Accumulated substrate: Heparan sulfate, dermatan sulfate Inheritance: AR
68
Lysosomal storage diseases - Hunter's syndrome
Findings: Mild Hurler's + aggressive behavior, no corneal clouding Deficient enzyme: Iduronate sulfatase Accumulated substrate: Heparan sulfate, dermatan sulfate Inheritance: XR
69
Lysosomal storage diseases - Gaucher's disease (most common)
Findings: Hepatosplenomegaly, aseptic necrosis of the femur, bone crisis, Gaucher's cells (macrophages that look like crumpled tissue paper) Deficient enzyme: β-glucocerebrosidase Accumulated substrate: Glucocerebroside Inheritance: AR
70
Lysosomal storage diseases - Fabry's disease
Findings: Peripheral neuropathy of hands/feet, angiokeratomas, cardiovascular/renal disease Deficient enzyme: α-galactosidase A Accumulated substrate: Ceramide trihexoside Inheritance: XR
71
Liver enzyme - Pancreatic lipase
degradation of dietary TG in small intestine
72
Liver enzyme - Lipoprotein lipase (LPL)
degradation of TG circulating in chylomicrons and VLDLs
73
Liver enzyme - Hormone-sensitive lipase
degradation of TG stored in adipocytes
74
Liver enzyme - Hepatic TG lipase (HL)
degradation of TG remaining in IDL
75
Lesch-Nyhan syndrome
X-linked recessive, defective purine salvage owing to absence of HGPRT, which converts hypoxanthine to IMP and guanine to GMP. Results in excess uric acid production. Findings: retardation, self-mutilation, aggression, hyperuricemia, gout, choreoathetosis
76
Kwashiokor
protein malnutrition resulting in skin lesions, edema, liver function (fatty change due to ↓ apolipoprotein synthesis). Clinical picture is a small child with swollen belly. Malnutrition, Edema, Anemia, fatty Liver.
77
Kartagener's syndrome
immotile cilia due to a dynein arm defect. Results in male and female infertility (sperm immotile), bronchiectasis, and recurrent sinusitis (bacteria and particles not pushed out); associated with situs inversus
78
Imprinting
At a single locus, only 1 allele is active; the other is inactive (imprinted / inactivated by methylation). Deletion of the active allele → disease Both syndromes due to inactivation or deletion of genes on chromosome 15 Can also occur as a result of uniparental disomy
79
Immunohistochemical stains: Vimentin
Connective tissue
80
Immunohistochemical stains: Neurofilaments
Neurons
81
Immunohistochemical stains: GFAP
Neuroglia
82
Immunohistochemical stains: Desmin
Muscle
83
Immunohistochemical stains: Cytokeratin
Epithelial cells
84
I-cell disease
(inclusion cell disease) - inherited lysosomal storage disorder; failure of addition of mannose-6-phosphate to lysosome proteins (enzymes are secreted outside the cell instead of being targeted to the lysosome). Results in coarse facial features, clouded corneas, restricted joint movement, and high plasma levels of lysosomal enzymes. Often fatal in childhood.
85
Heterochromatin
Condensed, transcriptionally inactive, sterically inaccessible
86
Hardy-Weinberg law assumptions (4)
1. No mutation occuring at the locus 2. No selection for any of the genotypes at the locus 3. Completely random mating 4. No migration
87
Glycogen storage diseases - Von Gierke's disease (type I)
Findings: severe fasting hypoglycemia, ↑↑ glycogen in liver, ↑ blood lactate, hepatomegaly Deficient enzyme: Glucose-6-phosphatase
88
Glycogen storage diseases - Pompe's disease (Type II)
Findings: Cardiomegaly and systemic findings leading to early death Deficient enzyme: Lysosomal α-1,4-glucosidase (acid maltase)
89
Glycogen storage diseases - McArdle's disease (type V)
Findings: ↑ glycogen in muscle, but cannot break it down, leading to painful muscle cramps, myoglobinuria with stenuous exercise Deficient enzyme: Skeletal muscle glycogen phosphorylase
90
Glycogen storage diseases - Cori's disease (type III)
Findings: milder form of type I with normal blood lactate levels Deficient enzyme: Debranching enzyme (α-1,6-glucosidase)
91
Genetic terms: Variable expression
Nature and severity of phenotype vary from 1 individual to another
92
Genetic terms: Uniparental disomy
Offspring receives 2 copies of a chromosome from 1 parent and no copies from the other parent
93
Genetic terms: Pleiotropy
1 gene has > 1 effect on an individual's phenotype
94
Genetic terms: Mosaicism
Occurs when cells in the body have different genetic makeup. Can be a germ-line mosaic, which may produce disease that is not carried by parent's somatic cells
95
Genetic terms: Loss of heterozygosity
If a patient inherits or develops a mutation in a tumor suppressor gene, the complementary allele must be deleted/mutated before cancer develops. This is not true of oncogenes.
96
Genetic terms: Locus heterogeneity
Mutations at different loci can produce the same phenotype
97
Genetic terms: Linkage disequilibrium
Tendency for certain alleles at 2 linked loci to occur together more often than expected by chance. Measured in a population, not in a family, and often varies in different populations.
98
Genetic terms: Incomplete penetrance
Not all individuals with a mutant genotype show the mutant phenotype
99
Genetic terms: Imprinting
Differences in phenotype depend on whether the mutation is of maternal or paternal origin
100
Genetic terms: Heteroplasmy
Presence of both normal and mutated mtDNA, resulting in variable expression in mitochondial inherited disease.
101
Genetic terms: Dominant negative mutation
Exerts a dominant effect. A heterozygote produces a nonfunctional altered protein that also prevents the normal gene product from functioning.
102
Genetic terms: Codominance
Neither of 2 alleles is dominant
103
Genetic terms: Anticipation
Severity of disease worsens or age of onset of disease is earlier in succeeding generations
104
Genetic code features: Universal
Genetic code is conserved throughout evolution
105
Genetic code features: Unambiguous
Each codon specifies only 1 amino acid
106
Genetic code features: Degenerate / redundant
More than 1 codon may code for the same amino acid
107
Genetic code features: Commaless, nonoverlapping
Read from a fixed starting point as a continuous sequence of bases
108
Findings: Orotic aciduria
↑ orotic acid in urine, megaloblastic anemia (does not improve with administration of vitamin B12 or folic acid), failure to thrive. No hyperammonemia (vs. OTC deficiency - ↑ orotic acid with hyperammonemia)
109
Euchromatin
Less condensed, transcriptionally active, sterically accessible
110
Ethanol metabolism: Fomepizole
inhibits alcohol dehydrogenase and is an antidote for methanol of ethylene glycol poisoning
111
Ethanol metabolism: Disulfiram (Antabuse)
inhibits acetaldehyde dehydrogenase (acetaldehyde accumulates, contributing to hangover symptoms)
112
Emphysema
can be caused by α1-antitrypsin deficiency, resulting in excess elastase activity
113
Elastin
Stretchy protein within lungs, large arteries, elastic ligaments, vocal cords, ligamenta flava (connect vertebrae → relaxed and stretched conformations). √. Rich in proline and glycine, nonglycosylated forms. √. Tropoelastin with fibrillin scaffolding. √. Broken down by elastase, which is normally inhibited by α1-antitrypsin.
114
Drugs that act on microtubules
1. Mebendazole / thiabendazole (antihelminthic) 2. Griseofulvin (antifungal) 3. Vincristine / vinblastine (anti-cancer) 4. Paclitaxel (anti-breast cancer) 5. Colchicine (anti-gout)
115
DNA replication: Single-stranded binding proteins
Prevent strands from reannealing
116
DNA replication: Replication disk
Y-shaped region alond DNA template where leading and lagging strands are synthesized
117
DNA replication: Proofreads
DNA polymerase III has 5' → 3' synthesis and proofreads with 3' → 5' exonuclease DNA polymerase I excises RNA primer with 5' → 3' exonuclease
118
DNA replication: Primase
Makes an RNA primer on which DNA polymerase III can initiate replication
119
DNA replication: Origin of replication
Particular sequence in genome where DNA replication begins. May be single (prokaryotes) or multiple (eukaryotes)
120
DNA replication: Helicase
Unwinds DNA template at replication fork
121
DNA replication: DNA topoisomerases
Create a nick in the helix to relieve supercoils created during replication
122
DNA replication: DNA polymerase III
Prokaryotic only. Elongates leading strand by adding deoxynucleotides to the 3' end. Elongates lagging strand until it reaches primer of preceeding fragment. 3' → 5' exonuclease activity "proofreads" each added nucleotide
123
DNA replication: DNA polymerase I
Prokaryotic only. Degrades RNA primer and fills in the gap with DNA
124
DNA replication: DNA ligase
Seals
125
DNA repair: Nucleotide excision repair
Specific endonucleases release the oligonucleotide containing damaged bases; DNA polymerase and ligase fill and reseal the gap, respectively. Mutated in xeroderma pigmentosum
126
DNA repair: Nonhomologous end joining
Brings together 2 ends of DNA fragments. No requirement for homology
127
DNA repair: Mismatch repair
Unmethylated, newly synthesized string is recognized, mismatched nucleotides are removed, and the gap is filled and resealed. Mutated in Hereditary nonpolyposis colorectal cancer (HNPCC)
128
DNA repair: Base excision repair
Specific glycosylases recognize and remove damaged bases, AP endonuclease cuts DNA at apyrimidinic site, empty sugar is removed, and the gap is filled and resealed.
129
Cytoskeletal elements: Microtubule (5)
Cilia, flagella, mitotic spindle, neurons, centrioles
130
Cytoskeletal elements: Intermediate filaments (5)
Vimentin, desmin, cytokeratin, glial fibrillary acid proteins (GFAP), neurofilaments
131
Cytoskeletal elements: Actin and myosin (4)
Microvilli, muscle contraction, cytokinesis, adherens junctions
132
Chédiak-Higashi syndrome
microtubule polymerization defect resulting in ↓ phagocytosis. Results in recurrent pyogenic infections, partial albinism, and peripheral neuropathy
133
Carbamoyl phosphate is involved in which 2 metabolic pathways?
1. de novo pyrimidine synthesis 2. urea cycle
134
Autosomal dominant diseases - von Hippel-Lindau disease
Findings: hemangioblastomas of retina/cerebellum/medulla; about half of affected individuals develop multiple bilateral renal cell carcinomas and other tumors. Associated with deletion of VHL gene (tumor suppressor) on chromosome 3 (3p). Results in constitutive expression of HIF (transcription factor) and activation of angiogenic growth factors. Von Hippel-Lindau = 3 words for chromosome 3.
135
Autosomal dominant diseases - Tuberous sclerosis
Findings: facial lesions (adenoma sebaceum), hyperpigmented "ash leaf spots" on skin, cortical and retinal hamartomas, seizures, mental retardation, renal cysts and renal angiomyolipomas, cardiac rhabdomyomas, ↑ incidence of astrocytomas. Incomplete penetrance, variable presentation.
136
Autosomal dominant diseases - Neurofibromatosis type 2
Bilateral acoustic schwannomas, juvenile cataracts. NF2 gene on chromosome 22; type 2 = 22.
137
Autosomal dominant diseases - Neurofibromatosis type 1 (von Recklinghausen's disease)
Findings: café-au-lait spots, neural tumors, Lisch nodules (pigmented iris hamartomas). Also marked by skeletal disorders (e.g., scoliosis) and optic pathway gliomas. On long arm of chromosome 17; 17 letters in von Recklinghausen.
138
Autosomal dominant diseases - Marfan's syndrome
Fibrillin gene mutation → connective tissue disorder affecting skeleton, heart, and eyes. Findings: tall with long extremities, pectus excavatum, hyperextensive joints, and long, tapering fingers and toes (arachnodactyly); cystic medial necrosis of aorta → aortic incompetence and dissecting aortic aneurysms; floopy mitral valve. Subluxation of lenses.
139
Autosomal dominant diseases - Huntington's disease
Findings: depression, progressive dementia, choreiform movements, caudate atrophy, and ↓ levels of GABA and ACh in the brain. Symptoms manifest in affected individuals between the ages 20 and 50. Gene located on chromosome 4; trinucleotide repeat disorder: (CAG)n. "Hunting 4 food"
140
Autosomal dominant diseases - Hereditary spherocytosis
Spheroid erythrocytes due to spectrin or ankyrin defect; hemolytic anemia; ↑ MCHC. Splenectomy is curative.
141
Autosomal dominant diseases - Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)
Inherited disorder of blood vessels. Findings: telangiectasia, recurrent epistaxis, skin discolorations, arteriovenous malformations (AVMs).
142
Autosomal dominant diseases - Familial hypercholesterolemia (hyperlipidemia type IIA)
Elevated LDL due to defective or absent LDL receptor. Heterozygotes (1:500) have cholesterol ≈ 300mg/dL. Homozygotes (very rare) have cholesterol ≈ 700+mg/dL, severe atherosclerotic disease early in life, and tendon xanthomas (classically in the Achilles tendon); MI may develop before age 20.
143
Autosomal dominant diseases - Familial adenomatous polyposis
Colon becomes covered with adenomatous polyps after puberty. Progresses to colon cancer unless resected. Mutation on chromosome 5 (APC gene); 5 letters in "polyp".
144
Autosomal dominant diseases - Autosomal-dominant polycystic kidney disease (ADPKD)
Formerly known as adult polycystic kidney disease. Always bilateral, massive enlargement of kidneys due to multiple large cysts. Patients present with flank pain, hematuria, hypertension, progressive renal failure. 90% of cases are due to mutation in APKD1 (chromosome 16; 16 letters in "polycystic kidney"). Associated with polycystic liver disease, berry aneurysms, mitral valve prolapse. Infantile form is recessive.
145
Autosomal dominant diseases - Achondroplasia
Cell-signaling defect of fibroblast growth factor (FGF) receptor 3. Results in dwarfism; short limbs, but head and trunk are normal size. Associated with advanced paternal age.
146
Angelman's syndrome
Deletion of normally active maternal allele Mental retardation, seizures, ataxia, inappropriate laughter ("happy puppet")
147
Amino acids necessary for purine synthesis
Glycine, Aspartate, Glutamine
148
Adenosine deaminase deficiency
Excess ATP and dATP imbalances nucleotide pool via feedback inhibition of ribonucleotide reductase → prevents DNA synthesis and thus ↓ lymphocyte count. One of the major causes of SCID.
